Difficulty: Medium
Average Score: 70%
Practice
Which of the following antidepressants is used for treatment of eating disorders,especially buliemia?
Correct answer
B
Rationale
In the context of pharmacology, understanding the specific uses of different classes of medications is crucial for effective clinical practice. In the case of treating eating disorders, particularly bulimia, the correct answer is B) Fluoxetine. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that has been shown to be effective in treating bulimia nervosa due to its ability to increase serotonin levels in the brain, which can help regulate mood and reduce binge-eating episodes.
A) Amitriptyline and C) Imipramine are tricyclic antidepressants that are not typically used as first-line treatments for eating disorders like bulimia. These medications have a different mechanism of action compared to SSRIs and are more commonly prescribed for conditions such as depression and certain types of chronic pain.
D) Tranylcypromine is a monoamine oxidase inhibitor (MAOI), which is another class of antidepressants with a different mechanism of action compared to SSRIs. MAOIs are not commonly used as a first-line treatment for bulimia due to their potential for serious side effects and interactions with certain foods and medications.
Educationally, this question highlights the importance of understanding the specific indications for different classes of antidepressant medications. It reinforces the need for healthcare providers to have a solid grasp of pharmacology to make informed decisions regarding drug therapy based on a patient's diagnosis and symptoms. This knowledge is essential for providing safe and effective care to individuals with eating disorders and other mental health conditions.
A) Amitriptyline and C) Imipramine are tricyclic antidepressants that are not typically used as first-line treatments for eating disorders like bulimia. These medications have a different mechanism of action compared to SSRIs and are more commonly prescribed for conditions such as depression and certain types of chronic pain.
D) Tranylcypromine is a monoamine oxidase inhibitor (MAOI), which is another class of antidepressants with a different mechanism of action compared to SSRIs. MAOIs are not commonly used as a first-line treatment for bulimia due to their potential for serious side effects and interactions with certain foods and medications.
Educationally, this question highlights the importance of understanding the specific indications for different classes of antidepressant medications. It reinforces the need for healthcare providers to have a solid grasp of pharmacology to make informed decisions regarding drug therapy based on a patient's diagnosis and symptoms. This knowledge is essential for providing safe and effective care to individuals with eating disorders and other mental health conditions.